These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32202569)

  • 1. An improved tumor-specific therapeutic strategy by the spatio-temporally controlled in situ formation of a Cu(ii) complex, leading to prompt cell apoptosis via photoactivation of a prodrug.
    Chaudhuri A; Mengji R; Venkatesh Y; Jana A; Pradeep Singh ND
    Chem Commun (Camb); 2020 Apr; 56(33):4559-4562. PubMed ID: 32202569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands.
    Deng J; Yu P; Zhang Z; Wang J; Cai J; Wu N; Sun H; Liang H; Yang F
    Eur J Med Chem; 2018 Oct; 158():442-452. PubMed ID: 30241011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper and Copper Complexes in Tumor Therapy.
    Wang Y; Tang T; Yuan Y; Li N; Wang X; Guan J
    ChemMedChem; 2024 Jun; 19(11):e202400060. PubMed ID: 38443744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cu
    Bykowska A; Komarnicka UK; Jeżowska-Bojczuk M; Kyzioł A
    J Inorg Biochem; 2018 Apr; 181():1-10. PubMed ID: 29348049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperidylthiosemicarbazones Cu(II) complexes with a high anticancer activity by catalyzing hydrogen peroxide to degrade DNA and promote apoptosis.
    Qi J; Yao Q; Tian L; Wang Y
    Eur J Med Chem; 2018 Oct; 158():853-862. PubMed ID: 30248656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.
    Jansson PJ; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2010 Aug; 53(15):5759-69. PubMed ID: 20597487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
    Mo Q; Deng J; Liu Y; Huang G; Li Z; Yu P; Gou Y; Yang F
    Eur J Med Chem; 2018 Aug; 156():368-380. PubMed ID: 30015073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural diversity of copper(II) complexes with N-(2-pyridyl)imidazolidin-2-ones(thiones) and their in vitro antitumor activity.
    Balewski Ł; Sączewski F; Bednarski PJ; Gdaniec M; Borys E; Makowska A
    Molecules; 2014 Oct; 19(10):17026-51. PubMed ID: 25342555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, crystal structure, and cytotoxic activity of novel cyclic systems in [1,2,4]thiadiazolo[2,3-a]pyridine benzamide derivatives and their copper(II) complexes.
    Adhami F; Safavi M; Ehsani M; Ardestani SK; Emmerling F; Simyari F
    Dalton Trans; 2014 Jun; 43(21):7945-57. PubMed ID: 24715093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
    Khan S; Malla AM; Zafar A; Naseem I
    PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper(II): Structure, anticancer activity and anticancer mechanism.
    Deng J; Gou Y; Chen W; Fu X; Deng H
    Bioorg Med Chem; 2016 May; 24(10):2190-8. PubMed ID: 27056799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.
    Mahendiran D; Kumar RS; Viswanathan V; Velmurugan D; Rahiman AK
    J Biol Inorg Chem; 2017 Oct; 22(7):1109-1122. PubMed ID: 28884428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.
    Tian M; Li J; Zhang S; Guo L; He X; Kong D; Zhang H; Liu Z
    Chem Commun (Camb); 2017 Nov; 53(95):12810-12813. PubMed ID: 29143019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing an Anticancer Copper(II) Pro-Drug Based on the His242 Residue of the Human Serum Albumin Carrier IIA Subdomain.
    Qi J; Zhang Y; Gou Y; Zhang Z; Zhou Z; Wu X; Yang F; Liang H
    Mol Pharm; 2016 May; 13(5):1501-7. PubMed ID: 27017838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative and antibacterial properties of biocompatible copper(II) complexes bearing chelating N,N-heterocycle ligands and potential mechanisms of action.
    Olar R; Badea M; Bacalum M; Răileanu M; Ruţă LL; Farcaşanu IC; Rostas AM; Vlaicu ID; Popa M; Chifiriuc MC
    Biometals; 2021 Oct; 34(5):1155-1172. PubMed ID: 34350537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper(ii) complexes with tridentate Schiff base-like ligands: solid state and solution structures and anticancer activity.
    Dankhoff K; Gold M; Kober L; Schmitt F; Pfeifer L; Dürrmann A; Kostrhunova H; Rothemund M; Brabec V; Schobert R; Weber B
    Dalton Trans; 2019 Oct; 48(40):15220-15230. PubMed ID: 31577284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High in vitro and in vivo antitumor activities of Ln(III) complexes with mixed 5,7-dichloro-2-methyl-8-quinolinol and 4,4'-dimethyl-2,2'-bipyridyl chelating ligands.
    Meng T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP
    Eur J Med Chem; 2019 May; 169():103-110. PubMed ID: 30870791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.
    Gou Y; Zhang Y; Zhang Z; Wang J; Zhou Z; Liang H; Yang F
    Mol Pharm; 2017 Jun; 14(6):1861-1873. PubMed ID: 28471669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of resveratrol is independent of Cu(II) complex formation in MCF-7 cell line.
    Andrade Volkart P; Benedetti Gassen R; Mühlen Nogueira B; Nery Porto B; Eduardo Vargas J; Arigony Souto A
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3238-3242. PubMed ID: 28647350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bis(dipyridophenazine)(2-(2-pyridyl)pyrimidine-4-carboxylic acid)ruthenium(II) complex with anticancer action upon photodeprotection.
    Joshi T; Pierroz V; Mari C; Gemperle L; Ferrari S; Gasser G
    Angew Chem Int Ed Engl; 2014 Mar; 53(11):2960-3. PubMed ID: 24500767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.